Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
H Jiang, H He, Y Chen, W Huang, J Cheng… - Journal of Experimental …, 2017 - rupress.org
The NLRP3 inflammasome has been implicated in the pathogenesis of a wide variety of
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …
Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases
The dysregulation of NLRP 3 inflammasome can cause uncontrolled inflammation and drive
the development of a wide variety of human diseases, but the medications targeting NLRP 3 …
the development of a wide variety of human diseases, but the medications targeting NLRP 3 …
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome
Inflammasomes are multiprotein complexes that drive inflammation and contribute to
protective immunity against pathogens and immune pathology in autoinflammatory …
protective immunity against pathogens and immune pathology in autoinflammatory …
Targeting the NLRP3 inflammasome in inflammatory diseases
MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
X Zhan, Q Li, G Xu, X Xiao, Z Bai - Frontiers in Immunology, 2023 - frontiersin.org
NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) is a cytosolic pattern
recognition receptor (PRR) that recognizes multiple pathogen-associated molecular patterns …
recognition receptor (PRR) that recognizes multiple pathogen-associated molecular patterns …
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
The NLRP3 inflammasome is a cytoplasmic multiprotein complex, the assembly of which
can be initiated in response to various exogenous or endogenous danger signals …
can be initiated in response to various exogenous or endogenous danger signals …
Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space
AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - ACS Publications
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …
preclinical models. As excitement in this field has grown, several companies have recently …
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
Inhibition of the NLRP3 inflammasome is a promising strategy for the development of new
treatments for inflammatory diseases. MCC950 is a potent and specific small-molecule …
treatments for inflammatory diseases. MCC950 is a potent and specific small-molecule …
Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction
Q Ma - Pharmacological reviews, 2023 - ASPET
The nucleotide-binding, oligomerization domain-like receptor family pyrin domain containing
3 (NLRP3) inflammasome is a multiprotein complex that combines sensing, regulation, and …
3 (NLRP3) inflammasome is a multiprotein complex that combines sensing, regulation, and …
Targeting the NLRP3 inflammasome in cardiovascular diseases
The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3
(NLRP3) inflammasome is an intracellular sensing protein complex that plays a major role in …
(NLRP3) inflammasome is an intracellular sensing protein complex that plays a major role in …